Anthony S. Gibney

Chief Financial Officer & Chief Business Officer at Fog Pharmaceuticals, Inc.

Anthony S. Gibney

Anthony S. Gibney

Chief Financial Officer & Chief Business Officer at Fog Pharmaceuticals, Inc.

Overview
Career Highlights

Fog Pharmaceuticals, Inc.

RelSci Relationships

774

Number of Boards

2

Birthday

1971

Age

49

Relationships
RelSci Relationships are individuals Anthony S. Gibney likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at InflaRx NV

Relationship likelihood: Strong

Chief Executive Officer & Founder at InflaRx NV

Relationship likelihood: Strong

Chief Scientific Officer & Founder at InflaRx NV

Relationship likelihood: Strong

Investment Manager at bm-t beteiligungsmanagement thüringen GmbH

Relationship likelihood: Strong

Chief Financial Officer at MorphoSys AG

Relationship likelihood: Strong

Board Secretary, Director & Deputy General Manager at Staidson (Beijing) Biopharmaceuticals Co., Ltd.

Relationship likelihood: Strong

Partner at GIG Ltd.

Relationship likelihood: Strong

Chair, San Diego Emerging Companies Practice at Latham & Watkins LLP

Relationship likelihood: Strong

Founder at LifeMine Therapeutics, Inc.

Relationship likelihood: Strong

Founder at Fog Pharmaceuticals, Inc.

Relationship likelihood: Strong

Paths to Anthony S. Gibney
Potential Connections via
Relationship Science
You
Anthony S. Gibney
Chief Financial Officer & Chief Business Officer at Fog Pharmaceuticals, Inc.
Education
Class of 1993
Career History
Chief Financial Officer & Chief Business Officer
2020 - Current

Fog Pharmaceuticals, Inc. develops pharmaceutical products. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane and is headquartered in Cambridge, MA.

Chief Business Officer & Executive Vice President
2018 - 2020

Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of innovative small molecule drug therapies. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.

Managing Director
2009 - 2017

Founded by Jeffrey Leerink in 1995, Leerink Swann LLC, formerly Leerink Swann & Co., is a full-service healthcare-focused investment banking firm that offers institutional sales, equity research, institutional trading, corporate finance and asset management services. The firm's investment banking activities include private placements, public offerings, private investment in public equity (PIPEs), registered direct offerings (RDOs and mergers & acquisitions.Leerink Swann's investment perspectives are driven by proprietary insights from MEDACorp., a network of over 35,000 physicians, researchers and healthcare professionals in North America, Europe, Asia and around the world with expertise in: clinical medicine, basic sciences, biomedical research, regulatory affairs, intellectual property, public health and policy, managed care, pharmacy management/pharmacy benefits management, healthcare administration, healthcare facilities, healthcare information technology, allied health services and healthcare consulting.Leerink Swann offers equity healthcare research coverage of the following areas: biotechnology, life science tools and diagnostics, pharmaceuticals, medical supplies and devices and healthcare services. The firm is also a market maker in over 350 NASDAQ equities.

Political Donations
Transactions
Details Hidden

Immunogen Inc. issued USD Common Stock

Details Hidden

ArQule, Inc. issued USD Common Stock

Details Hidden

Amicus Therapeutics, Inc. issued USD Common Stock

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Anthony S. Gibney. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Anthony S. Gibney's profile does not indicate a business or promotional relationship of any kind between RelSci and Anthony S. Gibney.